Amgen, Inc. (AMGN): What’s Its Next Catalyst?
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately.
Posts Tagged ‘NYSE:PFE’
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE): Take Two Dividend Stocks and Call Me in the Morning
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Who’s Suing Novartis AG (ADR) (NVS), And Why?
Would you hold a pharmaceutical product presentation in Hooters? That's just one of many alleged instances that the U.S.
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS), GlaxoSmithKline plc (ADR) (GSK) & Big Pharma’s Kickback Conundrum
Big pharma is a controversial industry. Along with tobacco companies, they are some of the most vilified businesses in the world.
Auto News: Tesla Motors Inc (TSLA)’s Subpoena, General Motors Company (GM) & Ford Motor Company (F)
Editor's Note: Related tickers: Tesla Motors Inc (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), Cardiovascular Systems Inc (NASDAQ:CSII), Pfizer...
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
D.R. Horton, Inc. (DHI), Verizon Communications Inc. (VZ), Pfizer Inc. (PFE): Exploding Home Prices Support Stocks
Blue-chip stocks are holding onto record highs this afternoon after new data showed that home prices are growing at the fastest rate in nearly seven years.
A Game-Changer For Pfizer Inc. (PFE)
The wealth-building power of compound interest will never cease to amaze me.
Pfizer Inc. (PFE) Holding Dow Jones Industrial Average (.DJI) Back
The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is unchanged following a worse-than-expected earnings release from Pfizer Inc.
How Will Merck & Co., Inc. (MRK)’s Earnings Fare Tomorrow?
Tomorrow, Merck & Co., Inc. (NYSE:MRK) will release its latest quarterly results.
GlaxoSmithKline plc (GSK), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Buy These Patent-Cliff Proof Stocks
Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic medicines and eventually leads to downfall in their sales.
Pfizer Inc. (PFE): Dow (.DJI) May Open Flat As It Disappoints
LONDON -- Stock index futures at 7 a.m.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY): A New Diabetes Duo Emerges
That's the message from today's announcement that Pfizer Inc. (NYSE:PFE) is out-licensing its diabetes drug candidate ertugliflozin to Merck & Co., Inc. (NYSE:MRK).
Raptor Pharmaceutical Corp. (RPTP), AVEO Pharmaceuticals, Inc. (AVEO) & Two FDA Decisions You Can’t Afford to Miss This Week
Last week we focused on five can't-miss earnings reports.
AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer’s Biggest Current and Upcoming Players
As I noted eight weeks ago, cancer statistics are both staggering and disappointing.
AbbVie Inc (ABBV)’s First Quarter: The Full Story of Humira And The 7 Dwarfs
In its first four months of existence, AbbVie Inc (NYSE:ABBV) rewarded investors with gains of almost 26%. Going into month five, those gains seem likely to increase.
Verizon Communications Inc. (VZ), Pfizer Inc. (PFE), AT&T Inc. (T): What Makes Dow (.DJI) Dividends So Important
Many investors rely on dividends for the income they need from their portfolios.
Pfizer Inc. (PFE), Baxter International (BAX), Quest Diagnostics (DGX) & Collecting Dividends From the Healthcare Sector
Continuing on with the dividend trend that my recent articles have been focusing upon, I’d like to now take a look at some solid healthcare companies.
Merck & Co., Inc. (MRK): How This Can Eventually Lead To Healthy Returns
In the big pharma sector, it can oftentimes be hit or miss when seeking the next big growth stock.
Avanir Pharmaceuticals, Inc. (AVNR), Medivation Inc (MDVN) & This Week In Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Pfizer Inc. (PFE), Wal-Mart Stores, Inc. (WMT): The Danger of Low Dividends
Earnings among S&P 500 companies are at an all-time high.
Johnson & Johnson (JNJ): Buying Isn’t for Growth Investors
If there's one health-care stock every investor knows by name, it's Johnson & Johnson (NYSE:JNJ).
Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Potential Game Changers for America’s No. 1 Killer
Heart disease kills nearly 600,000 Americans every year, making it the nation's No. 1 cause of death, according to the Centers for Disease Control and Prevention.
Ralph Lauren Corp (RL): The SEC Changes Its Course
Depending on how often you meet in glass-walled conference rooms, $125 might seem like a lot for a shirt.
Amgen, Inc. (AMGN): Is It a Buy Now?
When it comes to biotechs, Amgen, Inc. (NASDAQ:AMGN) qualifies for the senior citizen discount.
Eli Lilly & Co. (LLY): Will The Big Bets Pay Off?
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
GameStop Corp. (GME), Pfizer Inc. (PFE) and More: iShares Bolsters Factor ETF Lineup With 5 New Funds
BlackRock, Inc. (NYSE:BLK) iShares unit, the world's largest ETF issuer, added to its lineup of factor-driven ETFs today with the debut of five new funds.
Pfizer Inc. (PFE), Bristol Myers Squibb Co. (BMY), and Alzheimer’s Milkshakes: The Growth of Medical Nutrition
A milkshake is not foremost on most people’s list of treatments for the neurological disorder Alzheimer’s.
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK) & More: Drug Stocks on Citi’s Dividend Buy List
Barron's recently posted Citi's updated list of large, financially strong, high-yielding, dividend-paying companies.
This Day in History: Pfizer Inc. (PFE)’s Start, McDonald’s Corporation (MCD) Goes Public, and General Motors Company (GM) Dominates
Two members of the Dow Jones Industrial Average got started on their path to business leadership on April 21, and one former member reached one of the most impressive milestones...
Sarepta Therapeutics Inc (SRPT): FDA Says, “Call Me Maybe”
A lot has been written this week -- at The Fool and elsewhere -- about Sarepta Therapeutics Inc (NASDAQ:SRPT)' update on its meeting with the Food and Drug Administration.
Amgen, Inc. (AMGN): Is It Too Hot to Handle?
Shares of Amgen, Inc. (NASDAQ:AMGN) have returned over 65% in the past year; 109% if dividends are included. The S&P 500 has returned just over 13%.
Alkermes Plc (ALKS), Pfizer Inc. (PFE), Eli Lilly & Co. (LLY): These Biotech Investors Are Far From Depressed
The drug produced a statistically significant improvement in three different rating scales for depression compared to placebo.
Merck & Co., Inc. (MRK)’s Latest Drug and Strategy Concoctions
Merck & Co., Inc. (NYSE:MRK) reported a 7% decline in fourth-quarter profit after the patent expiry of Singulair on August 13, 2012, in the United States.
Abbott Laboratories (ABT): Will This Stock Hit New Highs After Earnings?
On Wednesday, Abbott Laboratories (NYSE:ABT) will release its latest quarterly results.
Pfizer Inc. (PFE), Exxon Mobil Corporation (XOM) & More Low Risk Dividend Growers From BlackRock
BlackRock focuses on low volatility dividend growers.
ACADIA Pharmaceuticals Inc. (ACAD), Astex Pharmaceuticals, Inc. (ASTX), Pfizer Inc. (PFE), and More: This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Pfizer Inc. (PFE), Hewlett-Packard Company (HPQ), and How The Dogs of the Dow Jones Industrial Average (.DJI) Beat Their Index This Week
The "Dogs of the Dow" is the name of one of the simplest dividend strategies for beating the market.
Alcoa Inc (AA), Pfizer Inc. (PFE), Hewlett-Packard Company (HPQ), And The Rest of Last Week’s Big Dow Jones Industrial Average 2 Minute (.DJI) Losers
This week officially kicked off earnings season, after Alcoa Inc (NYSE:AA) released its reports following the closing bell on Monday.
Pfizer Inc. (PFE), The Home Depot, Inc. (HD) and The Top Three Stocks This Week
Earnings season got under way this week, and investors are still seeing bullish signs in the tea leaves.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE), NIKE, Inc. (NKE), Lululemon Athletica inc. (LULU), and The Big Business of the Boston Marathon
The world's oldest annual marathon gets under way this weekend. It's a big event for the runners, but it's also a huge one for the city of Boston and numerous companies.
Pfizer Inc. (PFE) & More…a ‘Breakthrough’ May Be on the Way for Breast Cancer Patients
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade to complete.
Pfizer Inc. (PFE), Hewlett-Packard Company (HPQ): Are The Year’s Best Dow Jones Industrial Average (.DJI) Stocks Worth Buying?
The Dow Jones Industrial Average (INDEXDJX:.DJI) has been on a tear this year.
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): This Stock Is Fine, So What Just Happened to Mine?
While the Dow Jones Industrial Average (INDEXDJX:.DJI) continues to climb to new heights on little more than a central bank-induced asset levitation scheme and closing the day...
Merck & Co., Inc. (MRK): This Stock Rocked, So What Just Happened to Mine?
Merck & Co., Inc. (NYSE:MRK) stock soared almost 3% Wednesday to close in on a new 52-week high after the pharmaceutical giant announced the FDA accepted its new drug application...
Cisco Systems, Inc. (CSCO), Chevron Corporation (CVX) And The Dow (.DJI)’s Top Stocks on a Record-Setting Day
Thanks to a few top stocks, the Dow Jones Industrial Average managed to once again set a new all-time closing high at 14,865.
ACADIA Pharmaceuticals Inc. (ACAD): FDA Throws This Stock a Juicy Bone
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin...
Johnson & Johnson (JNJ): One Potential Roadblock for the Stock’s ‘Run-Up’
There are several factors that could hurt other stocks that shouldn't be an issue for Johnson & Johnson (NYSE:JNJ). For example.
